Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Effect of Cardiac Resynchronization Therapy on Longitudinal and Circumferential Left Ventricular Mechanics by Velocity Vector Imaging: Description and Initial Clinical Application of a Novel Method Using High-Frame Rate B-Mode Echocardiographic Images
- Cardiac Resynchronization Therapy CRT has emerged as an important method to treat patient with symptomatic heart failure with evidence of intraventricular dyssynchrony. Tissue Doppler imaging by echocardiography has been shown to be an excellent tool for the assessment of mechanical left ventricular dyssynchrony and the selection of patients for CRT....
- White papers 2005-11-22
Additional Resources
- Guidant Receives Exclusive Expanded Indication for Heart Failure Treatment; Thousands of Additional Patients Now Eligible to Receive Cardiac Resynchronization Therapy Defibrillators
- INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced that the U.S. Food and Drug Administration FDA has approved an expanded indication for the company's portfolio of cardiac resynchronization therapy defibrillators (CRT-D). The expanded indication makes Guidant's cardiac resynchronization therapy defibrillators available to thousands more heart failure patients,...
- Research articles 2004-09-15
- St. Jude Medical to Study Benefits of Cardiac Resynchronization Therapy in Heart Failure Patients with Mechanical Dyssynchrony
- ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) today announced first patient enrollment in the Resynchronization Therapy In Normal QRS RETHINQ clinical trial, an important study that may further identify heart failure patients who can benefit from cardiac resynchronization therapy CRT.
- Research articles 2005-08-23
- FDA Approves St. Jude Medical's High-Voltage Cardiac Resynchronization Therapy Device System
- ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) announced today approval by the U.S. Food and Drug Administration FDA of its high-voltage cardiac resynchronization therapy (CRT-D) device system, including the EpicTM HF and AtlasR+ HF ICDs and the QuickSiteR left-heart pacing lead. The approval was based on the results...
- Research articles 2004-06-30
- FDA Grants Approval to Begin Landmark Cardiac Resynchronization Therapy Study, EchoCRT
- BERLIN & SAN FRANCISCO -- BIOTRONIK, the pioneer in wireless remote monitoring technologies for patients with implantable cardiac pacemakers and defibrillators, announced today the FDA approval to begin an international, prospective, randomized, controlled clinical trial to investigate the use of Cardiac Resynchronization Therapy CRT in heart failure HF patients with...
- Research articles 2008-05-16
- FDA Approves V-V Timing in St. Jude Medical Epic HF and Atlas+ HF Cardiac Resynchronization Therapy Devices
- ST. PAUL, Minn. -- St. Jude Medical, Inc. (NYSE:STJ) announced today that it has received U.S. Food and Drug Administration FDA approval to add V-V ventricle to ventricle timing to new models of the St. Jude Medical EpicTM HF and AtlasR+ HF family of cardiac resynchronization therapy devices (CRT-Ds). The...
- Research articles 2004-11-18
- Medtronic Initiates ''Concerto AT'' Study in United States; Clinicians Begin Implanting New Cardiac Resynchronization Therapy-Defibrillator with Atrial Therapies
- MINNEAPOLIS -- Medtronic, Inc., (NYSE:MDT) today announced the first implants in the United States of the Medtronic ConcertoTM Cardiac Resynchronization Therapy Defibrillator (CRT-D) with Atrial Therapies AT. CRT devices send tiny electrical impulses to the heart muscle to resynchronize the contractions of the heart's lower chambers, helping the heart pump...
- Research articles 2006-02-01
- TomTec Introduces Its New Diagnostic Tool for Cardiac Resynchronization Therapy at Cardiostim 2006
- UNTERSCHLEISSHEIM, Germany -- Echo meets electrophysiology. TomTec Imaging Systems - well known for its expertise in 3D/4D Echocardiography - is introducing its new diagnostic tool for Cardiac Resynchronization Therapy CRT. The 4D LV-AnalysisC software is a tool for comprehensive left ventricular analysis and bases on three dimensional echocardiographic...
- Research articles 2006-06-13
- BIOTRONIK Announces the First Implantation of Implantable Cardioverter Defibrillator with Cardiac Resynchronization and Atrial Tachyarrhythmia Therapies
- Business Editors/Health/Medical Writers LAKE OSWEGO, Ore.--BUSINESS WIRE--Nov. 13, 2003 BIOTRONIK, Inc. announced today the first US implantation of a unique implantable cardioverter defibrillator ICD that provides three essential therapies in a single device: cardiac resynchronization therapy CRT for treating heart failure, atrial therapy for atrial tachyarrhythmias, and ICD...
- Research articles 2003-11-13
- Medtronic Commences Clinical Trial of Innovative Delivery Technology for Heart Failure Patients with Implanted Cardiac Resynchronization Devices
- MINNEAPOLIS -- Medtronic Inc. (NYSE:MDT) today announced the first clinical implants in the United States of the Medtronic Attain Ability[TM] over-the-wire lead (Model 4196), a dual-electrode left ventricular LV lead for use in heart failure patients with cardiac resynchronization therapy CRT devices. These implantable devices are used to resynchronize the...
- Research articles 2007-03-20
- Guidant to Launch New Wireless Heart Failure Communication Technology System in U.S.; Guidant Announces Full Availability of Cardiac Rhythm Management Product Line
- INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced U.S. Food and Drug Administration FDA approval of its CONTAK RENEWALR 3 RF cardiac resynchronization therapy defibrillator (CRT-D) for heart failure patients and the ZOOM R LATITUDETM programmer. The RENEWAL 3 RF CRT-D is Guidant's first wandless cardiac resynchronization...
- Research articles 2005-08-19
- ORLive Presents: Cardiac Resynchronization Therapy for Heart Failure, a Bi-Ventricular Implantable Cardioverter Defibrillator Implant
- Tufts-New England Medical Center will conduct a live Webcast of a bi-ventricular defibrillator implant on Wednesday, March 7, at 6 PM EST on www.OR-Live.com . The surgical procedure will be performed by cardiac electrophysiologist Jonathan Weinstock, MD, and moderated by N.A. Mark Estes, MD, Director of...
- Research articles 2007-02-22
- REMINDER: ORLive Presents: Cardiac Resynchronization Therapy for Heart Failure, a Bi-Ventricular Implantable Cardioverter Defibrillator Implant
- Tufts-New England Medical Center will conduct a live Webcast of a bi-ventricular defibrillator implant on Wednesday, March 7, at 6 PM EST on www.OR-Live.com . The surgical procedure will be performed by cardiac electrophysiologist Jonathan Weinstock, MD, and moderated by N.A. Mark Estes, MD, Director of...
- Research articles 2007-03-07
- Medtronic Receives FDA Approval for the InSync Maximo Cardiac Resynchronization Therapy Defibrillator
- MINNEAPOLIS -- High energy, quick charge times help offer increased safety in treating sudden cardiac arrest for heart failure patients
- Research articles 2004-06-28
- Guidant Announces FDA Approval of Wireless Home Patient Management System; Innovative Technology Directed Toward Compliance in Heart Failure Patients at Risk of Sudden Cardiac Death
- INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced U.S. Food and Drug Administration FDA approval of the LATITUDER Communicator, and secure data storage system. These elements represent the final components of the LATITUDE Patient Management system, which presently can be used with the CONTAK RENEWALR 3RF cardiac...
- Research articles 2005-09-19
- Medtronic Announces Japanese Introduction of Cardiac Resynchronization Therapy with Defibrillator Capabilities for Heart Failure Patients
- MINNEAPOLIS & TOKYO -- First Reimbursement Approvals for CRT-D Allow Japanese Patients Access to Advanced Therapies for the Treatment of Both Heart Failure and Sudden Cardiac Arrest
- Research articles 2006-07-07
- FDA Approves Two New Medtronic Cardiac Devices with Conexus™ Wireless Telemetry
- Demo of the ConcertoTM Cardiac Resynchronization Therapy-Defibrillator (CRT-D) and VirtuosoTM Implantable Cardioverter Defibrillator ICD on Site Thursday at Heart Rhythm 2006
- Research articles 2006-05-17
- BIOTRONIK Announces Food and Drug Administration Approvable Status for Revolutionary Heart Failure Therapy System
- BOSTON -- Full Cardiac Resynchronization Therapy System combines superior performance and versatility with BIOTRONIK's pioneering Home Monitoring technology
- Research articles 2006-05-19
- Women Less Likely to Receive Heart Device Therapy But Survive With it Longer Than Men.
- Byline: Mayo Clinic DALLAS, Nov. 15 AScribe Newswire -- Women with heart failure are less likely than men to receive cardiac resynchronization therapy CRT -- an implantable device shown to enhance quality of life for people with heart failure; yet women who get CRT...
- Research articles 2005-11-15
- BIOTRONIK: EchoCRT, the Largest Trial of Its Kind, Enrolls First Patients Today
- The EchoCRT Study Will Investigate the Life-Saving Benefits of Cardiac Resynchronization Therapy in Patients with Heart Failure Who Currently Do Not Receive Device Therapy BERLIN, Germany & LAKE OSWEGO, Ore. -- BIOTRONIK announced today the enrollment of the first patient into the EchoCRT Echocardiography guided Cardiac Resynchronization Therapy study....
- Research articles 2008-08-26
- << Previous
- page 1 of 1
- Next >>
Presented by American Express